Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Back to Agenda

How to Convert a New Device (PMA) into an Old (510(k)) Device: The De Novo 510(k)

Session Chair(s)

Michael Swit, JD

Senior Director, Legal, Regulatory Affairs

Varian, United States

Under the 1976 Device Amendments, new technology that is not substantially equivalent to a marketed device is automatically put in Class III. This session reviews how to get that class switched to a less risky, less expensive regulatory path.

Learning Objective : Discuss how new technology leads to automatic Class III status for a device, even if not risky; Explain how the FDAMA created a new mechanism to avoid automatic Class III status by the de novo petition process; Examine the advantages and burdens of the process.

Speaker(s)

Overview of the De Novo Process

Michael Swit, JD

Varian, United States

Senior Director, Legal, Regulatory Affairs

The De Novo Pathway: Opportunities and Pitfalls - A Petitioner’s View from the Trenches

Michael Drues, PhD

Vascular Sciences, United States

Founder and President

Have an account?

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

How to Convert a New Device (PMA) into an Old (510(k)) Device: The De Novo 510(k)

Session Chair(s)

Michael Swit, JD

Learning Objective : Discuss how new technology leads to automatic Class III status for a device, even if not risky; Explain how the FDAMA created a new mechanism to avoid automatic Class III status by the de novo petition process; Examine the advantages and burdens of the process.

Speaker(s)

Overview of the De Novo Process

The De Novo Pathway: Opportunities and Pitfalls - A Petitioner’s View from the Trenches

Be informed and stay engaged.